• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec12
Innoviva Receives FDA Approval for New Gonorrhea Treatment Nuzolvence
22:42
H.C. Wainwright reiterates buy rating on Innoviva, sets price target at $45
11:17
Nov6
Innoviva released FY2025 9 Months earnings on November 5 (EST), actual revenue USD 296.72 M, actual EPS USD 1.1113
04:00
Innoviva released FY2025 Q3 earnings on November 5, 2025 (EST), actual revenue USD 107.8 M (forecast USD 91.3 M), actual EPS USD 1.0815 (forecast USD 0.4825)
04:00
Oct2
Analyst issues a sell rating on Innoviva
06:31
Aug7
Innoviva released FY2025 Semi-Annual earnings on August 6 (EST), actual revenue USD 188.92 M, actual EPS USD 0.24
03:00

Schedules & Filings

Schedules
Filings
Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 107.8 M, Net Income 89.91 M, EPS 1.0815

Aug6
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 100.28 M, Net Income 63.69 M, EPS 0.7727

May7
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 88.63 M, Net Income -46.58 M, EPS -0.7428

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More